Paul Dodd
Director/Board Member at Merck Sharp & Dohme (Holdings) Pty Ltd.
Profile
Paul Dodd is currently a Director at Merck Sharp & Dohme (Holdings) Pty Ltd.
He was formerly a Director at Viralytics Pty Ltd.
Paul Dodd active positions
| Companies | Position | Start |
|---|---|---|
Merck Sharp & Dohme (Holdings) Pty Ltd.
 Merck Sharp & Dohme (Holdings) Pty Ltd. MiscellaneousMiscellaneous Merck Sharp & Dohme (Holdings) Pty Ltd. operates as an investment holding company. The company is headquartered in Macquarie Park, Australia. | Director/Board Member | - |
Former positions of Paul Dodd
| Companies | Position | End |
|---|---|---|
| VIRALYTICS LTD. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
Merck Sharp & Dohme (Holdings) Pty Ltd.
Merck Sharp & Dohme (Holdings) Pty Ltd. MiscellaneousMiscellaneous Merck Sharp & Dohme (Holdings) Pty Ltd. operates as an investment holding company. The company is headquartered in Macquarie Park, Australia. | Miscellaneous |
- Stock Market
- Insiders
- Paul Dodd
